Arpita R. Dave

Dr. Arpita R. Dave

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2022 in Cells
Verified
Journal Article
Open access
PDF file
ENEunice Sze Yin Ng
Eunice Sze Yin Ng
NKNermin Kady
Nermin Kady
JHJane Hu
Jane Hu
ADArpita R. Dave
Arpita R. Dave
ZJZhichun Jiang
Zhichun Jiang
RRRoxana A. Radu
Roxana A. Radu
Recessive Stargardt disease (STGD1) is an inherited retinopathy caused by mutations in the ABCA4 gene. The ABCA4 protein is a phospholipid-retinoid flippase in the outer segments of photoreceptors and the internal membranes of retinal pigment epithelial (RPE) cells. Here, we show that RPE cells derived via induced pluripotent stem-cell from a molecularly and clinically diagnosed STGD1 patient exhibited reduced ABCA4 protein and diminished activity compared to a normal subject. Consequently, STGD1 RPE cells accumulated intracellular autofluorescence-lipofuscin and displayed increased complement C3 activity. The level of C3 inversely correlated with the level of CD46, an early negative regulator of the complement cascade. Persistent complement dysregulation led to deposition of the membrane attack complex on the surface of RPE cells, decrease in transepithelial resistance, and subsequent cell death. These findings are strong evidence of complement-mediated RPE cell damage in STGD1, in the absence of photoreceptors, caused by reduced CD46 regulatory protein.

17 February 2022 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
PDF file
ADArpita R. Dave
Arpita R. Dave
PPPrakash P. P Pillai
Prakash P. P Pillai

2 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
ADArpita R. Dave
Arpita R. Dave
ATAnela Tosevska
Anela Tosevska
Marco MorselliMarco Morselli
Marco Morselli
ETEmily Tom
Emily Tom
MPMatteo Pellegrini
Matteo Pellegrini
RRRoxana A. Radu
Roxana A. Radu
Stargardt disease (STGD1), the most common inherited juvenile macular degeneration, is caused by biallelic mutations in the ABCA4 gene. Currently, there is no approved treatment. In this study, we investigated early-stage epigenomic changes in the retinal pigment epithelium (RPE) of Abca4-/- mice, a well-established model of STGD1. Reduced representation bisulfite sequencing (RRBS) revealed hypermethylation of gene regions associated with disease-related pathways, implicating methyl-CpG-binding protein 2 (MeCP2) and RE1-silencing transcription factor (REST) as potential regulators. Notably, DNA methylation of a subset of genes preceded their transcriptional change and disease phenotypes in Abca4-/- RPE. Together with the detected age-dependent increase in MeCP2 levels in Abca4-/- RPE, these findings suggest that early DNA methylation changes may contribute to RPE dysfunction and eventual cell loss in STGD1.

Verified
Journal Article
Open access
PDF file
ADArpita R. Dave
Arpita R. Dave
ATAnela Tosevska
Anela Tosevska
Marco MorselliMarco Morselli
Marco Morselli
ETEmily Tom
Emily Tom
MPMatteo Pellegrini
Matteo Pellegrini
RRRoxana A. Radu
Roxana A. Radu
Stargardt disease (STGD1), the most common inherited juvenile macular degeneration, is caused by biallelic mutations in the ABCA4 gene. Currently, there is no approved treatment. In this study, we investigated early-stage epigenomic changes in the retinal pigment epithelium (RPE) of Abca4-/- mice, a well-established model of STGD1. Reduced representation bisulfite sequencing (RRBS) revealed hypermethylation of gene regions associated with disease-related pathways, implicating methyl-CpG-binding protein 2 (MeCP2) and RE1-silencing transcription factor (REST) as potential regulators. Notably, DNA methylation of a subset of genes preceded their transcriptional change and disease phenotypes in Abca4-/- RPE. Together with the detected age-dependent increase in MeCP2 levels in Abca4-/- RPE, these findings suggest that early DNA methylation changes may contribute to RPE dysfunction and eventual cell loss in STGD1.